We analyzed the correlation between laboratory parameters and clinical data (including age, QMGs, AchR-Ab concentration, and disease duration) in MG patients at different stages to explore the clinical significance of the expression of OX40 and OX40L (Table 5). This evidence concerns the gene TNFRSF4 and myasthenia gravis.